metricas
covid
Buscar en
Revista de Psiquiatría y Salud Mental (English Edition)
Toda la web
Inicio Revista de Psiquiatría y Salud Mental (English Edition) Role of serotonergic polymorphisms in the clinical severity of the panic disorde...
Journal Information
Vol. 2. Issue 1.
Pages 35-41 (January 2009)
Share
Share
Download PDF
More article options
Vol. 2. Issue 1.
Pages 35-41 (January 2009)
Full text access
Role of serotonergic polymorphisms in the clinical severity of the panic disorder
Implicación de polimorfismos serotoninérgicos en la gravedad clínica del trastorno de pánico
Visits
1082
Pilar A. Sáiza,
Corresponding author
frank@uniovi.es

Corresponding author.
, Sara Martínez-Barrondob, María P. García-Portillaa, Paul Corcorana,c, Blanca Moralesd, María-Teresa Bascarana, Begoña Paredese, Victoria Álvarezd, Eliecer Cotod, Juan M. Fernándeza, Manuel Bousoñoa, Julio Bobesa
a Department of Psychiatry, School of Medicine, University of Oviedo, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, 33006 Oviedo, Spain
b Mental Health Services of Asturias (SESPA), Mieres, Spain
c National Suicide Research Foundation, Cork, Ireland
d Laboratory of Molecular Genetics, Hospital Universitario Central de Asturias, Oviedo, Spain
e Emergency Room, San Agustin Hospital, Aviles, Spain
This item has received
Article information
Abstract
Introduction and objectives

To investigate the association between three serotonergic polymorphisms (A-1438G [rs6311] of the HTR2A gene, STin2 VNTR and 5-HTTLPR of the SLC6A4 gene) and the severity of panic and depression symptomatology among mental health outpatients with diagnosis of panic disorder (PD).

Methods

92 unrelated PD outpatients (DSM-IV criteria) from a homogeneous Spanish Caucasian population (mean age±SD, 35.9±12.4 years; 28 [30.4%] males) were assessed using the Panic and Agoraphobia Scale (PAS), and the Hamilton Depression Rating Scale (HDRS), and genotyped using standard methods.

Results

Age of onset of PD varied by STin2 VNTR genotype (F=3.21; p=0.045). On average, onset of PD occurred earlier for those with the 10/10 than for those with the 12/12 genotype (25.1 versus 33.3; p=0.043). No relationship was found between A-1438G, 5-HTTLPR, and STin2 VNTR genotypes and PAS or HDRS total scores. Variation in scores on the HDRS Anxiety subscale by A-1438G genotype almost reached statistical significance (F=3.03; p=0.053). Post hoc pairwise comparisons showed higher anxiety levels among A/G than among A/A carriers (4.1 versus 2.9; p=0.043). Finally, variation in scores on the Preoccupied with Health subscale of the PAS by 5-HTTLPR genotype approached statistical significance (F=2.56; p=0.083). Post hoc pairwise comparisons showed higher scores among L/S than among L/L carriers (2.4 versus 1.4; p=0.078).

Conclusions

Our data provide support of an involvement of the serotonin system, particularly, the HTR2A gene in the severity of PD.

Keywords:
Genetic association
Panic disorder
Polymorphisms
Serotonin transporter
Serotonin 2A receptor
Resumen
Inroducción y objetivos

Investigar la relación entre tres polimorfismos serotoninérgicos (A-1438G [rs6311] del gen HTR2A, STin2 VNTR y 5-HTTLPR del gen SLC6A4) y la gravedad de la sintomatología de pánico y depresión en pacientes ambulatorios con un diagnóstico de trastorno de pánico (TP).

Métodos

Se evaluó a un total de 92 pacientes ambulatorios con TP (criterios diagnósticos del DSM-IV) no emparentados, de una población española caucásica homogénea (media de edad±desviación estándar de 35,9±12,4 años; 28 [30,4%] varones) con el empleo de las escalas Panic and Agoraphobia Scale (PAS) y Hamilton Depression Rating Scale (HDRS), y se determinó su genotipo con métodos estándar.

Resultados

La edad de inicio del TP variaba según el genotipo STin2 VNTR (F=3,21; p=0,045). En promedio, el inicio del TP se produjo antes en los pacientes con el genotipo 10/10 que en los que presentaban el genotipo 12/12 (25,1 frente a 33,3; p=0,043). No se observó relación alguna entre los genotipos A-1438G, 5-HTTLPR y STin2 VNTR y las puntuaciones totales de las escalas PAS o HDRS. La variación en las puntuaciones de la subescala de Ansiedad de la HDRS en función del genotipo A-1438G alcanzaba casi la significación estadística (F=3,03; p=0,053). Las comparaciones post hoc de datos emparejados pusieron de manifiesto un grado de ansiedad mayor en los portadores del genotipo A/G que en los portadores del A/A (4,1 frente a 2,9; p=0,043). Por último, la variación de las puntuaciones de la subescala de Preocupación por la Salud de la PAS, en función del genotipo 5-HTTLPR, se aproximaba a la significación estadística (F=2,56; p=0,083). Las comparaciones post hoc para datos emparejados mostraron unas puntuaciones más altas en los portadores del genotipo L/S que en los portadores del L/L (2,4 frente a 1,4; p=0,078).

Conclusiones

Nuestros datos respaldan la participación del sistema serotoninérgico, y en especial del gen HTR2A, en la gravedad del TP.

Palabras clave:
Asociación genética
Trastorno de pánico
Polimorfismos
Transportador de serotonina
Receptor de serotonina 2A
Full text is only aviable in PDF
References
[1.]
National Institute of Mental Health. Health's Genetics Workgroup. Genetics and mental disorders. Biol Psychiatry. 1999;45:559-602.
[2.]
W. Maier, D. Lichtermann, J. Minges, A. Oehrlein, P. Franke.
A controlled family study in panic disorder.
J Psychiatr Res, 27 (1993), pp. 79-87
[3.]
J. Mendlewicz, G. Papadimitriou, J. Wilmotte.
Family study of panic disorder: comparison with generalized anxiety disorder, major depression, and normal subjects.
Psychiatr Gen, 3 (1993), pp. 73-78
[4.]
M.M. Weissman, P. Wickramaratne, P.B. Adams, J.D. Lish, E. Horwath, D. Charney, et al.
The relationship between panic disorder and major depression: a family study.
Arch Gen Psychiatry, 50 (1993), pp. 767-780
[5.]
R. Kessler.
Review: mayor anxiety disorders all have substantive familial aggregation.
Evid Based Ment Health, 5 (2002), pp. 92
[6.]
R.R. Crowe, R. Noyes, A.F. Wilson, R.C. Elston, L.J. Ward.
A linkage study of panic disorder.
Arch Gen Psychiatry, 44 (1987), pp. 933-937
[7.]
J.I. Nurnberger, W. Berrettini.
Psychiatric genetics.
Chapman and Hall Medical, (1998),
[8.]
M. Gratacòs, M. Nadal, R. Martín-Santos, M.A. Pujana, J. Gago, B. Peral, et al.
A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders.
Cells, 106 (2001), pp. 367-379
[9.]
M. Tabiner, S. Youings, N. Dennis, D. Baldwin, C. Buis, A. Mayers, et al.
Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines.
Am J Hum Genet, 72 (2003), pp. 535-538
[10.]
J. Schumacher, A.C. Otte, T. Becker, Y. Sun, T.F. Wienker, B. Wirth, et al.
No evidence for DUP25 in patients with panic disorder using a quantitative real-time PCR approach.
Hum Genet, 114 (2003), pp. 115-117
[11.]
P.A. Saiz, M.P. Garcia-Portilla, C. Arango, B. Morales, M.T. Bascaran, S. Martinez-Barrondo, et al.
Association study between obsessivecompulsive disorder and serotonergic candidate genes.
Prog Neuropsychopharmacol Biol Psychiatry, 32 (2008), pp. 765-770
[12.]
Y. Inada, H. Yoneda, J. Koh, J. Sakai, A. Himei, Y. Kinoshita, et al.
Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene.
Psychiatry Res, 118 (2003), pp. 25-31
[13.]
E. Maron, A. Lang, G. Tasa, L. Liivlaid, I. Tõru, A. Must, et al.
Associations between serotonin-related gene polymorphisms and panic disorder.
Int J Neuropsychopharmacol, 8 (2005), pp. 261-266
[14.]
C. Rothe, D. Koszycki, J. Bradwejn, N. King, V. de Luca, S. Shaikh, et al.
Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany.
Neurosci Lett, 363 (2004), pp. 276-279
[15.]
S. Martinez-Barrondo, P.A. Saiz, B. Morales, M.P. Garcia-Portilla, E. Coto, V. Alvarez, et al.
[Serotonin gene polymorphisms in patients with panic disorder].
Actas Esp Psiquiatr, 33 (2005), pp. 210-215
[16.]
P.G. Unschuld, M. Issing, A. Erhardt, S. Lucae, S. Kloiber, M. Kohli, et al.
Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder.
Am J Med Genet B Neuropsychiatr Genet, 144B (2007), pp. 424-429
[17.]
H.K. Yoon, J.C. Yang, H.J. Lee, Y.K. Kim.
The association between serotonin-related gene polymorphisms and panic disorder.
J Anxiety Disord, 22 (2008), pp. 1529-1534
[18.]
K.P. Lesch, D. Bengel, A. Heils, S.Z. Sabol, B.D. Greenberg, S. Petri, et al.
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.
Science, 274 (1996), pp. 1527-1531
[19.]
J. Deckert, M. Catalano, A. Heils, D. Di Bella, F. Friess, E. Politi, et al.
Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder.
Psychiatr Genet, 7 (1997), pp. 45-47
[20.]
H. Ishiguro, T. Arinami, K. Yamada, Y. Otsuka, M. Toru, H. Shibuya.
An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population.
Psychiatry Clin Neurosci, 51 (1997), pp. 333-335
[21.]
S. Matsushita, T. Muramatsu, M. Kimura, O. Shirakawa, T. Mita, T. Nakai, et al.
Serotonin transporter gene regulatory region polymorphism and panic disorder.
Mol Psychiatry, 2 (1997), pp. 390-392
[22.]
K. Ohara, M. Nagai, Y. Suzuki, M. Ochiai, K. Ohara.
Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene.
Psychiatry Res, 81 (1998), pp. 277-279
[23.]
S.P. Hamilton, G.A. Heiman, F. Haghighi, S. Mick, D.F. Klein, S.E. Hodge, et al.
Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder.
Psychiatr Genet, 9 (1999), pp. 1-6
[24.]
J. Samochowiec, A. Hajduk, A. Samochowiec, J. Horodnicki, G. Stepien, A. Grzywacz, et al.
Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum.
Psychiatry Res, 128 (2004), pp. 21-26
[25.]
O.F. Olesen, B. Bennike, E.S. Hansen, P. Koefoed, D.P. Woldbye, T.G. Bolwig, et al.
The short/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample.
Psychiatr Genet, 15 (2005), pp. 159
[26.]
W. Kim, Y.H. Choi, K.S. Yoon, D.Y. Cho, C.U. Pae, J.M. Woo.
Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population.
Prog Neuropsychopharmacol Biol Psychiatry, 30 (2006), pp. 1413-1418
[27.]
L.J. Strug, R. Suresh, A.J. Fyer, A. Talati, P.B. Adams, W. Li, et al.
Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR).
Mol Psychiatry, (2008), pp. 79
[28.]
C. Blaya, G.A. Salum, M.S. Lima, S. Leistner-Segal, G.G. Manfro.
Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and panic disorder: a systematic review and meta-analysis.
Behav Brain Funct, 3 (2007), pp. 41
[29.]
C. Wachleski, C. Blaya, G.A. Salum, V. Vargas, S. Leister-Segal, G.C. Manfro.
Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and personality traits in asymptomatic patients with panic disorder.
Neurosci Lett, 431 (2008), pp. 173-178
[30.]
G. Perna, E. Favaron, D. di Bella, R. Bussi, L. Bellodi.
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.
Neuropsychopharmacology, 30 (2005), pp. 2230-2235
[31.]
A. MacKenzie, J. Quinn.
A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo.
Proc Natl Acad Sci USA, 96 (1999), pp. 15251-15255
[32.]
World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Amended by the 41st World Medical Assembly, Hong Kong, September, 1989.
[33.]
B. Bandelow.
Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale.
Int Clin Psychopharmacol, 10 (1995), pp. 73-81
[34.]
M. Hamilton.
A rating scale for depression.
J Neurol Neurosurg Psychiatry, 23 (1960), pp. 56-62
[35.]
S.A. Miller, D.D. Dykes, H.F. Polesky.
A simple salting out procedure for extracting DNA from human nucleated cells.
Nucleic Acids Res, 16 (1988), pp. 1215
[36.]
J.W. Smoller, J.F. Rosenbaum, J. Biederman, J. Kennedy, D. Dai, S.R. Racette, et al.
Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition.
Biol Psychiatry, 54 (2003), pp. 1376-1381
[37.]
E. Maron, T. Nikopensius, S. Köks, S. Altmäe, E. Heinaste, K. Vabrit, et al.
Association study of 90 candidate polymorphisms in panic disorder.
Psychiatr Genet, 15 (2005), pp. 17-24
[38.]
X.Z. Hu, R.H. Lipsky, G. Zhu, L.A. Akhtar, J. Taubman, B.D. Greenberg, et al.
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.
Am J Hum Genet, 78 (2006), pp. 815-826
Copyright © 2009. SEP y SEPB
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos